Prostate cancer is one of the most commonly diagnosed malignant neoplasms. In Hungary, 4000-4500 men are diagnosed annually, which is below the European incidence. In contrast, the Hungarian prostate cancer mortality clearly exceeds the EU average. This is probably due to the lack of awareness and early recognition of prostate cancer. At an early stage, prostate cancer can be cured, 5-year survival is almost 100%, while in metastatic form it is only 28%. There are several treatment options available for prostate cancer. Since it is multiplex within the organ and the cancer foci are histopathologically heterogeneous, only the treatment of the whole prostate is curative. Radical prostatectomy is the only curative treatment that can provide a complete healing and increased life expectancy in men with prostate cancer. It is recommended to be performed in men with a life expectancy of at least 10 years. During surgery, the prostate is removed, along with its capsule, seminal vesicles on both sides and pelvic lymph nodes. During surgery, the urinary continence and, if possible, erectile function should be preserved.
|Number of pages||6|
|Publication status||Published - Mar 19 2019|
ASJC Scopus subject areas